These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 12840598)
1. Troglitazone inhibits isolated cell proliferation, and induces apoptosis in isolated rat mesangial cells. Tsuchiya T; Shimizu H; Shimomura K; Mori M Am J Nephrol; 2003; 23(4):222-8. PubMed ID: 12840598 [TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation. Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168 [TBL] [Abstract][Full Text] [Related]
3. Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro. Routh RE; Johnson JH; McCarthy KJ Kidney Int; 2002 Apr; 61(4):1365-76. PubMed ID: 11918743 [TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature. Guan Y; Zhang Y; Schneider A; Davis L; Breyer RM; Breyer MD Am J Physiol Renal Physiol; 2001 Dec; 281(6):F1036-46. PubMed ID: 11704554 [TBL] [Abstract][Full Text] [Related]
5. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells. Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617 [TBL] [Abstract][Full Text] [Related]
6. Negative growth effects of ciglitazone on kidney interstitial fibroblasts: role of PPAR-gamma. Parameswaran N; Hall CS; Bomberger JM; Sparks HV; Jump DB; Spielman WS Kidney Blood Press Res; 2003; 26(1):2-9. PubMed ID: 12697971 [TBL] [Abstract][Full Text] [Related]
7. PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase. Ghosh SS; Gehr TW; Ghosh S; Fakhry I; Sica DA; Lyall V; Schoolwerth AC Kidney Int; 2003 Jul; 64(1):52-62. PubMed ID: 12787395 [TBL] [Abstract][Full Text] [Related]
8. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells. Toyoda M; Takagi H; Horiguchi N; Kakizaki S; Sato K; Takayama H; Mori M Gut; 2002 Apr; 50(4):563-7. PubMed ID: 11889080 [TBL] [Abstract][Full Text] [Related]
9. Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells. Nicholas SB; Kawano Y; Wakino S; Collins AR; Hsueh WA Hypertension; 2001 Feb; 37(2 Pt 2):722-7. PubMed ID: 11230363 [TBL] [Abstract][Full Text] [Related]
11. Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells. Okura T; Nakamura M; Takata Y; Watanabe S; Kitami Y; Hiwada K Eur J Pharmacol; 2000 Nov; 407(3):227-35. PubMed ID: 11068018 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor gamma ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide. Yoshida K; Hirose Y; Tanaka T; Yamada Y; Kuno T; Kohno H; Katayama M; Qiao Z; Sakata K; Sugie S; Shibata T; Mori H Cancer Sci; 2003 Apr; 94(4):365-71. PubMed ID: 12824906 [TBL] [Abstract][Full Text] [Related]
13. Troglitazone inhibits glutamine metabolism in rat mesangial cells. Routh R; McCarthy K; Welbourne T Am J Physiol Endocrinol Metab; 2002 Jan; 282(1):E231-8. PubMed ID: 11739105 [TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effect of fluvastatin and thiazolidinedione in mesangial cells of diabetic rats. Okada M; Yanagida H; Kuwajima H; Takemura T Pediatr Nephrol; 2004 Jan; 19(1):26-32. PubMed ID: 14634862 [TBL] [Abstract][Full Text] [Related]
15. [The effect of peroxisome proliferator-activated receptor alpha and gamma ligands on free fatty acid-induced INS-1 cell impairment]. Yang LY; Yang YN; Chen ZJ Zhonghua Nei Ke Za Zhi; 2003 Dec; 42(12):847-50. PubMed ID: 14728875 [TBL] [Abstract][Full Text] [Related]
16. Troglitazone induces a cellular acidosis by inhibiting acid extrusion in cultured rat mesangial cells. Welbourne T; Su G; Coates G; Routh R; McCarthy K; Battarbee H Am J Physiol Regul Integr Comp Physiol; 2002 Jun; 282(6):R1600-7. PubMed ID: 12010740 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of troglitazone on tumor necrosis factor alpha-induced expression of monocyte chemoattractant protein-1 in human mesangial cells. Ohta MY; Nagai Y; Takamura T; Nohara E; Kobayashi K Metabolism; 2000 Feb; 49(2):163-6. PubMed ID: 10690939 [TBL] [Abstract][Full Text] [Related]
18. Troglitazone enhances glycolysis and improves intracellular glucose metabolism in rat mesangial cells. Asano T; Wakisaka M; Yoshinari M; Nakamura S; Doi Y; Fujishima M Metabolism; 2000 Mar; 49(3):308-13. PubMed ID: 10726906 [TBL] [Abstract][Full Text] [Related]
19. Troglitazone (CS-045) inhibits beta-cell proliferation rate following stimulation of insulin secretion in HIT-T 15 cells. Ohtani KI; Shimizu H; Sato N; Mori M Endocrinology; 1998 Jan; 139(1):172-8. PubMed ID: 9421412 [TBL] [Abstract][Full Text] [Related]
20. Effects of type-2 diabetes and troglitazone on the expression patterns of small intestinal sugar transporters and PPAR-gamma in the Zucker diabetic fatty rat. Corpe C; Sreenan S; Burant C Digestion; 2001; 63(2):116-23. PubMed ID: 11244250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]